Genworth Financial Inc
GNW NYSE Life Insurance Financials FY2016βFY2025
What Genworth Financial Inc does
No business description yet.
- Legal name
- GENWORTH FINANCIAL INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001628280-26-012828
0001276520
Revenue and margins
Genworth Financial Inc had $7.3B of revenue in fiscal 2025, up 0.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Genworth Financial Inc returned $247M to shareholders in fiscal 2025. The diluted share count fell 5.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Genworth Financial Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.6B | $1.8B | $2.2B | $2.0B | $2.0B |
| Debt incl. finance leases | $1.9B | $1.6B | $1.6B | $1.5B | $1.5B |
| Net debt / EBITDA | 0.4x | β0.2x | β2.1x | β | β |
| Debt / equity | 0.1x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 3.0x | 7.7x | 0.3x | β | β |
| Total assets | $99.2B | $89.7B | $90.8B | $86.8B | $88.1B |
| Total liabilities | $82.9B | $81.3B | $82.5B | $77.4B | $78.3B |
| Shareholders' equity | $15.5B | $7.6B | $7.5B | $8.4B | $8.8B |
| Net debt (β = net cash) | $328M | β$188M | β$631M | β$530M | β$523M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 6 / 7 | 5 / 7 | 5 / 7 | 5 / 7 | 7 / 7 | 5 / 7 | 5 / 7 | 5 / 7 |
| Accruals ratio | β2.1% | β1.7% | β1.5% | β1.7% | β1.7% | 0.4% | β0.1% | β0.6% | 0.2% | β0.1% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $8.4B | $7.5B | $7.9B | $7.7B | $8.3B | $7.8B | $7.5B | $7.5B | $7.3B | $7.3B |
| Provision for credit losses | β | β | $0.0M | β | β | β | β | β | β | β |
| Operating income | β$316M | $530M | β$5.0M | $355M | $310M | $474M | $818M | $41.0M | β | β |
| Interest expense | $337M | $266M | $256M | $231M | $195M | $160M | $106M | $118M | $115M | $105M |
| Pretax income | $320M | $127M | $137M | $521M | $928M | $1.1B | $1.4B | $303M | $595M | $433M |
| Income tax | $358M | β$406M | $70.0M | $139M | $230M | $248M | $319M | $104M | $158M | $84.0M |
| Net income | β$277M | $817M | $119M | $343M | $178M | $850M | $916M | $76.0M | $299M | $223M |
| Diluted EPS | β$0.56 | $1.63 | $0.24 | $0.67 | $0.35 | $1.65 | $1.79 | $0.16 | $0.68 | $0.54 |
| Diluted shares | 0.50B | 0.50B | 0.50B | 0.51B | 0.51B | 0.51B | 0.51B | 0.47B | 0.44B | 0.41B |
| Cash flow | ||||||||||
| Cash from operations | $1.9B | $2.6B | $1.6B | $2.1B | $2.0B | $437M | $1.0B | $597M | $88.0M | $327M |
| Depreciation and amortization | $498M | $392M | $348M | $408M | $463M | $384M | $326M | $264M | $249M | $231M |
| Stock-based compensation | $32.0M | $31.0M | $35.0M | $26.0M | $39.0M | $40.0M | $37.0M | $49.0M | $51.0M | $58.0M |
| Acquisitions | $0.0M | $5.0M | $0.0M | $0.0M | β | β | β | β | β | β |
| Share buybacks | β | β | β | β | $0.0M | $0.0M | $64.0M | $296M | $189M | $247M |
| Dividends and buybacks | β | β | β | β | $0.0M | $0.0M | $64.0M | $296M | $189M | $247M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.8B | $2.9B | $2.0B | $3.3B | $1.0B | $1.6B | $1.8B | $2.2B | $2.0B | $2.0B |
| Total debt | $4.2B | $4.2B | $3.7B | $3.3B | $3.4B | $1.9B | $1.6B | $1.6B | $1.5B | $1.5B |
| Goodwill | $14.0M | β | β | β | β | β | β | β | β | β |
| Intangible assets | β | β | β | β | $157M | $143M | $203M | $198M | $197M | β |
| Total assets | $104.7B | $105.3B | $100.9B | $101.3B | $105.7B | $99.2B | $89.7B | $90.8B | $86.8B | $88.1B |
| Total liabilities | $90.2B | $90.0B | $86.7B | $86.7B | $89.9B | $82.9B | $81.3B | $82.5B | $77.4B | $78.3B |
| Shareholders' equity | $12.6B | $13.4B | $12.5B | $14.2B | $15.3B | $15.5B | $7.6B | $7.5B | $8.4B | $8.8B |
| Margins | ||||||||||
| Operating margin | β3.8% | 7.1% | β0.1% | 4.6% | 3.7% | 6.1% | 10.9% | 0.5% | β | β |
| EBITDA margin | 2.2% | 12.3% | 4.3% | 9.9% | 9.3% | 11.0% | 15.3% | 4.1% | β | β |
| Net margin | β3.3% | 10.9% | 1.5% | 4.5% | 2.1% | 10.9% | 12.2% | 1.0% | 4.1% | 3.1% |
| Returns | ||||||||||
| Return on capital | β1.5% | 3.6% | β0.0% | 1.8% | 1.3% | 2.3% | 8.4% | 0.4% | β | β |
| Return on equity | β2.2% | 6.3% | 0.9% | 2.6% | 1.2% | 5.5% | 7.9% | 1.0% | 3.8% | 2.6% |
| Return on assets | β0.3% | 0.8% | 0.1% | 0.3% | 0.2% | 0.8% | 1.0% | 0.1% | 0.3% | 0.3% |
| Return on tangible equity | β2.2% | 6.1% | 1.0% | 2.4% | 1.2% | 5.5% | 12.3% | 1.0% | 3.6% | 2.5% |
| Growth | ||||||||||
| Revenue growth | β | β10.2% | 5.2% | β2.5% | 7.5% | β5.6% | β4.2% | β0.1% | β2.6% | 0.1% |
| Net income growth | β | β | β85.4% | 188.2% | β48.1% | 377.5% | 7.8% | β91.7% | 293.4% | β25.4% |
| EPS growth | β | β | β85.3% | 179.2% | β47.8% | 371.4% | 8.5% | β91.1% | 325.0% | β20.6% |
| Share count change | β | 0.6% | β0.2% | 1.9% | 0.4% | 0.6% | β0.7% | β7.0% | β7.5% | β5.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 7.7x | 1.5x | 5.1x | 0.0x | 3.1x | 0.4x | β0.2x | β2.1x | β | β |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.2x | 0.2x | 0.1x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | β0.9x | 2.0x | β0.0x | 1.5x | 1.6x | 3.0x | 7.7x | 0.3x | β | β |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.4% | 0.4% | 0.4% | 0.3% | 0.5% | 0.5% | 0.5% | 0.7% | 0.7% | 0.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 6.0 | 5.0 | 5.0 | 5.0 | 7.0 | 5.0 | 5.0 | 5.0 |
| Accruals ratio | β2.1% | β1.7% | β1.5% | β1.7% | β1.7% | 0.4% | β0.1% | β0.6% | 0.2% | β0.1% |
Source: SEC EDGAR XBRL filings (CIK 0001276520). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.